173 related articles for article (PubMed ID: 36581888)
1. Targeting SOST using a small-molecule compound retards breast cancer bone metastasis.
Sun L; Zhang Y; Chen G; Ji Y; Ma Q; Qiao X; Wu S; Zhou L; Bu J; Zhu X; Zhang X; Jiang X; Liu C; Li X; Liu Y; Yang Y; Liu C
Mol Cancer; 2022 Dec; 21(1):228. PubMed ID: 36581888
[TBL] [Abstract][Full Text] [Related]
2. Protection From Glucocorticoid-Induced Osteoporosis by Anti-Catabolic Signaling in the Absence of Sost/Sclerostin.
Sato AY; Cregor M; Delgado-Calle J; Condon KW; Allen MR; Peacock M; Plotkin LI; Bellido T
J Bone Miner Res; 2016 Oct; 31(10):1791-1802. PubMed ID: 27163932
[TBL] [Abstract][Full Text] [Related]
3. SOST Inhibits Prostate Cancer Invasion.
Hudson BD; Hum NR; Thomas CB; Kohlgruber A; Sebastian A; Collette NM; Coleman MA; Christiansen BA; Loots GG
PLoS One; 2015; 10(11):e0142058. PubMed ID: 26545120
[TBL] [Abstract][Full Text] [Related]
4. Cortical bone adaptation to a moderate level of mechanical loading in male Sost deficient mice.
Yang H; Büttner A; Albiol L; Julien C; Thiele T; Figge C; Kramer I; Kneissel M; Duda GN; Checa S; Willie BM
Sci Rep; 2020 Dec; 10(1):22299. PubMed ID: 33339872
[TBL] [Abstract][Full Text] [Related]
5. Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells.
Taipaleenmäki H; Farina NH; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
Oncotarget; 2016 Nov; 7(48):79032-79046. PubMed ID: 27738322
[TBL] [Abstract][Full Text] [Related]
6. Reduction of SOST gene promotes bone formation through the Wnt/β-catenin signalling pathway and compensates particle-induced osteolysis.
Zhang ZH; Jia XY; Fang JY; Chai H; Huang Q; She C; Jia P; Geng C; Xu W
J Cell Mol Med; 2020 Apr; 24(7):4233-4244. PubMed ID: 32134561
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
[TBL] [Abstract][Full Text] [Related]
8. Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activity.
Chang MK; Kramer I; Keller H; Gooi JH; Collett C; Jenkins D; Ettenberg SA; Cong F; Halleux C; Kneissel M
J Bone Miner Res; 2014 Jan; 29(1):29-42. PubMed ID: 23901037
[TBL] [Abstract][Full Text] [Related]
9. Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1/Notch, TGF-β and IL-6 signaling pathways.
Wu C; Chen M; Sun Z; Ye Y; Han X; Qin Y; Liu S
J Ethnopharmacol; 2019 Mar; 232():145-154. PubMed ID: 30576770
[TBL] [Abstract][Full Text] [Related]
10. Concurrent antitumor and bone-protective effects of everolimus in osteotropic breast cancer.
Browne AJ; Kubasch ML; Göbel A; Hadji P; Chen D; Rauner M; Stölzel F; Hofbauer LC; Rachner TD
Breast Cancer Res; 2017 Aug; 19(1):92. PubMed ID: 28793923
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow endothelium-targeted therapeutics for metastatic breast cancer.
Mai J; Huang Y; Mu C; Zhang G; Xu R; Guo X; Xia X; Volk DE; Lokesh GL; Thiviyanathan V; Gorenstein DG; Liu X; Ferrari M; Shen H
J Control Release; 2014 Aug; 187():22-9. PubMed ID: 24818768
[TBL] [Abstract][Full Text] [Related]
12. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading.
Tu X; Rhee Y; Condon KW; Bivi N; Allen MR; Dwyer D; Stolina M; Turner CH; Robling AG; Plotkin LI; Bellido T
Bone; 2012 Jan; 50(1):209-17. PubMed ID: 22075208
[TBL] [Abstract][Full Text] [Related]
13. Effects of Long-Term Sclerostin Deficiency on Trabecular Bone Mass and Adaption to Limb Loading Differ in Male and Female Mice.
Albiol L; Büttner A; Pflanz D; Mikolajewicz N; Birkhold AI; Kramer I; Kneissel M; Duda GN; Checa S; Willie BM
Calcif Tissue Int; 2020 Apr; 106(4):415-430. PubMed ID: 31873756
[TBL] [Abstract][Full Text] [Related]
14. Sirt1 is a regulator of bone mass and a repressor of Sost encoding for sclerostin, a bone formation inhibitor.
Cohen-Kfir E; Artsi H; Levin A; Abramowitz E; Bajayo A; Gurt I; Zhong L; D'Urso A; Toiber D; Mostoslavsky R; Dresner-Pollak R
Endocrinology; 2011 Dec; 152(12):4514-24. PubMed ID: 21952235
[TBL] [Abstract][Full Text] [Related]
15. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin.
Robling AG; Niziolek PJ; Baldridge LA; Condon KW; Allen MR; Alam I; Mantila SM; Gluhak-Heinrich J; Bellido TM; Harris SE; Turner CH
J Biol Chem; 2008 Feb; 283(9):5866-75. PubMed ID: 18089564
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1.
Fang Y; Chen Y; Yu L; Zheng C; Qi Y; Li Z; Yang Z; Zhang Y; Shi T; Luo J; Liu M
J Natl Cancer Inst; 2013 Jan; 105(1):47-58. PubMed ID: 23178439
[TBL] [Abstract][Full Text] [Related]
17. TGF-β regulates sclerostin expression via the ECR5 enhancer.
Loots GG; Keller H; Leupin O; Murugesh D; Collette NM; Genetos DC
Bone; 2012 Mar; 50(3):663-9. PubMed ID: 22155511
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer-derived bone metastasis can be effectively reduced through specific c-MET inhibitor tivantinib (ARQ 197) and shRNA c-MET knockdown.
Previdi S; Abbadessa G; Dalò F; France DS; Broggini M
Mol Cancer Ther; 2012 Jan; 11(1):214-23. PubMed ID: 22027690
[TBL] [Abstract][Full Text] [Related]
19. HDAC5 controls MEF2C-driven sclerostin expression in osteocytes.
Wein MN; Spatz J; Nishimori S; Doench J; Root D; Babij P; Nagano K; Baron R; Brooks D; Bouxsein M; Pajevic PD; Kronenberg HM
J Bone Miner Res; 2015 Mar; 30(3):400-11. PubMed ID: 25271055
[TBL] [Abstract][Full Text] [Related]
20. Sclerostin expression in skeletal sarcomas.
Shen J; Meyers CA; Shrestha S; Singh A; LaChaud G; Nguyen V; Asatrian G; Federman N; Bernthal N; Eilber FC; Dry SM; Ting K; Soo C; James AW
Hum Pathol; 2016 Dec; 58():24-34. PubMed ID: 27498059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
